Clemizole hydrochloride
SIGMA/SML1447 - ≥98% (HPLC)
Synonym: 1-
CAS Number: 1163-36-6
Empirical Formula (Hill Notation): C19H20ClN3 · HCl
Molecular Weight: 362.30
EC Number: 214-605-4
MDL Number: MFCD00051435
Linear Formula: C19H20ClN3 · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C19H20ClN3.ClH/c20-16- |
| InChI key | DNFMJYXRIMLMBZ-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | ClC(C=C1)=CC=C1CN2C(CN3CC |
| solubility | H2O: 2 mg/mL, clear (warmed) |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Clemizole is a potent and preferring inhibitor of TRPC5 that efficiently blocks heterologously expressed homomeric TRPC5 channels as well as heteromeric TRPC1:TRPC5 channels. Clemizole is a potent and selective H1 histamine receptor antagonist. Clemizole inhibited binding of HCV RNA by NS4B inhibit HCV RNA replication in cell culture. |
| Biochem/physiol Actions: | Clemizole is a potent and preferring inhibitor of TRPC5; Antihistaminic. |
| Biochem/physiol Actions: | Clemizole is an antihistamine and an inhibitor of NS4B (nonstructural protein 4B) RNA of HCV (hepatitis C virus). Studies in Scn1α (sodium channel, voltage-gated, type I, α) Zebrafish mutant show that this drug has the potential as a therapeutic agent in Dravet Syndrome treatment. |
| General description: | Clemizole is a potent anti-allergic drug. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


